FIGURE 1
FROM:
Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer
M K Oehler, D C Fischer, M Orlowska-Volk, F Herrle, D G Kieback, M C P Rees and R Bicknell
BACK TO ARTICLEFigure 1.

Characterisation of the anti-ADM monoclonal antibody 171. (A) Solid-phase ELISA using antibody 171 against ADM (circle), amylin (square) and CGRP (triangle). (B) Immunoblotting of supernatant from transfected ADM-overexpressing RL95.2 cell clones and synthetic ADM. (C) Immunostaining of ADM-overexpressing RL95.2 cell clones and controls. (Brown indicates immunostaining.)
